StockMacro
Menu

NanoViricides

$1.14 -25% in 6 monthsMarket cap $29.1M

NNVC on XASE, Health Care, NanoViricides Inc., job postings

Measures activity, not value. Not investment advice.

Cash of $2.6M against a $12.2M net loss while shares fell 30% in six months.

  • WatchNews coverage 9.0 times its usual week, 9 articles in 7 days

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.

Industry
Pharmaceutical preparations (Health Care)
Employees
7
Website
nanoviricides.com
Listed
NYSE American, US
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $0, net loss $5.7M.
Quarter to 31 Dec 2021: revenue $0, net income -$1.9MQuarter to 31 Dec 2021: revenue $0, net income -$1.9MQuarter to 31 Mar 2022: revenue $0, net income -$1.8MQuarter to 31 Mar 2022: revenue $0, net income -$1.8MQuarter to 30 Jun 2022: revenue –, net income -$1.8MQuarter to 30 Sep 2022: revenue $0, net income -$1.6MQuarter to 30 Sep 2022: revenue $0, net income -$1.6MQuarter to 31 Dec 2022: revenue $0, net income -$1.7MQuarter to 31 Dec 2022: revenue $0, net income -$1.7MQuarter to 31 Mar 2023: revenue $0, net income -$1.7MQuarter to 31 Mar 2023: revenue $0, net income -$1.7MQuarter to 30 Jun 2023: revenue $0, net income -$3.6MQuarter to 30 Jun 2023: revenue $0, net income -$3.6MQuarter to 30 Sep 2023: revenue $0, net income -$2.0MQuarter to 30 Sep 2023: revenue $0, net income -$2.0MQuarter to 31 Dec 2023: revenue $0, net income -$2.1MQuarter to 31 Dec 2023: revenue $0, net income -$2.1MQuarter to 31 Mar 2024: revenue $0, net income -$1.9MQuarter to 31 Mar 2024: revenue $0, net income -$1.9MQuarter to 30 Jun 2024: revenue $0, net income -$2.4MQuarter to 30 Jun 2024: revenue $0, net income -$2.4MQuarter to 30 Sep 2024: revenue $0, net income -$3.1MQuarter to 30 Sep 2024: revenue $0, net income -$3.1MQuarter to 31 Dec 2024: revenue $0, net income -$2.0MQuarter to 31 Dec 2024: revenue $0, net income -$2.0MQuarter to 31 Mar 2025: revenue $0, net income -$2.2MQuarter to 31 Mar 2025: revenue $0, net income -$2.2MQuarter to 30 Jun 2025: revenue $0, net income -$2.1MQuarter to 30 Jun 2025: revenue $0, net income -$2.1MQuarter to 30 Sep 2025: revenue $0, net income -$1.8MQuarter to 30 Sep 2025: revenue $0, net income -$1.8MQuarter to 31 Dec 2025: revenue $0, net income -$2.2MQuarter to 31 Dec 2025: revenue $0, net income -$2.2MQuarter to 31 Mar 2026: revenue $0, net income -$2.0MQuarter to 31 Mar 2026: revenue $0, net income -$2.0MQuarter to 30 Jun 2026: revenue $0, net income -$2.2MQuarter to 30 Jun 2026: revenue $0, net income -$2.2MQuarter to 30 Sep 2026: revenue $0, net income -$5.7MQuarter to 30 Sep 2026: revenue $0, net income -$5.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $5.7M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$0-$5.7M
30 Jun 2026$0-$2.2M
31 Mar 2026$0-$2.0M
31 Dec 2025$0-$2.2M
30 Sep 2025$0-$1.8M
30 Jun 2025$0-$2.1M
31 Mar 2025$0-$2.2M
31 Dec 2024$0-$2.0M
30 Sep 2024$0-$3.1M
30 Jun 2024$0-$2.4M
31 Mar 2024$0-$1.9M
31 Dec 2023$0-$2.1M
30 Sep 2023$0-$2.0M
30 Jun 2023$0-$3.6M
31 Mar 2023$0-$1.7M
31 Dec 2022$0-$1.7M
30 Sep 2022$0-$1.6M
30 Jun 2022–-$1.8M
31 Mar 2022$0-$1.8M
31 Dec 2021$0-$1.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$12.2M -$8.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.53 -$0.51
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -179% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$7.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $2.6M $1.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$2.6M (net cash) -$1.1M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.25
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 4.5 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
NanoViricidesNNVC (this company) $29.1Mloss–––
Rein TherapeuticsRNTX $29.1Mloss–––
AYTU BioPharmaAYTU $28.9Mloss0.49-8.1%-34.3%
NextCureNXTC $29.5Mloss–––
Serina TherapeuticsSER $29.8Mloss–––
ProMIS NeurosciencesPMN $28.4Mloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+2.0%

50 13F filers vs 49

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

9.1%

2.3M shares held by 13F filers (30 Sep 2026) of 25.6M outstanding (14 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.2%

812K shares sold short (30 Oct 2026) of 25.6M outstanding (14 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.2

812K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-29%

1.1M shares sold short in the report before, 812K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

32%

32% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 50%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

9

9 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

9.0×

9 articles in the last 7 days; its usual week has 1.

Price $1.14 on 20 Nov 2026, -8.1% over 12 months (12-month range $0.85 to $1.86)

  • Sharp change
  • 8-K and other filings
Revenue per quarter. Revenue $0 in the latest quarter.
Capital spending per quarter. Capital spending $1 in the latest quarter, -100% on a year earlier.
Institutional holders (13F filers). 50 13F filers reported holding it in the latest 13F quarter, +52% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: insider net buying (open market), h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
29 Sep 20268-K and other filingsDirector or officer change
29 Sep 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jun 2026Sharp changeShort interest spike: short interest spike, 1.7M vs usual 237K (2026-05-29); 12.3x the same period a year earlier
31 Mar 2026Sharp changeShort interest spike: short interest spike, 805K vs usual 185K (2026-03-13); 4.2x the same period a year earlier
17 Mar 2026Sharp changeShort interest spike: short interest spike, 963K vs usual 161K (2026-02-27); 6.8x the same period a year earlier
3 Mar 2026Sharp changeShort interest spike: short interest spike, 844K vs usual 143K (2026-02-13); 6.0x the same period a year earlier
25 Feb 20268-K and other filingsPrivate placement of securities (Form D)
17 Feb 2026Sharp changeShort interest spike: short interest spike, 790K vs usual 143K (2026-01-30); 3.8x the same period a year earlier
3 Feb 2026Sharp changeShort interest spike: short interest spike, 658K vs usual 143K (2026-01-15); 3.6x the same period a year earlier
1 Oct 20258-K and other filingsDirector or officer change
1 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Aug 20248-K and other filingsDirector or officer change
9 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Sep 20238-K and other filingsReport will be filed late
1 Aug 2023Sharp changeShort interest spike: short interest spike, 626K vs usual 171K (2023-07-14); 3.3x the same period a year earlier
11 Oct 20228-K and other filingsDirector or officer change
11 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Sep 20228-K and other filingsReport will be filed late
Revenue per quarter
Quarter ended 31 Dec 2021: $0; public on 15 Feb 2022
Quarter ended 31 Mar 2022: $0; public on 17 May 2022
Quarter ended 30 Sep 2022: $0; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $0; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $0; public on 16 May 2023
Quarter ended 30 Jun 2023: $0; public on 14 Oct 2023
Quarter ended 30 Sep 2023: $0; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $0; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $0; public on 16 May 2024
Quarter ended 30 Jun 2024: $0; public on 28 Sep 2024
Quarter ended 30 Sep 2024: $0; public on 15 Nov 2024
Quarter ended 31 Dec 2024: $0; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $0; public on 16 May 2025
Quarter ended 30 Jun 2025: $0; public on 30 Sep 2025
Quarter ended 30 Sep 2025: $0; public on 15 Nov 2025
Quarter ended 31 Dec 2025: $0; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $0; public on 16 May 2026
Quarter ended 30 Jun 2026: $0; public on 29 Sep 2026
Quarter ended 30 Sep 2026: $0; public on 17 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $185K, +2060% on a year earlier; public on 15 Feb 2022
Quarter ended 31 Mar 2022: $39K, -64% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $75K, -11% on a year earlier; public on 14 Oct 2022
Quarter ended 30 Sep 2022: $45K, +83% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $45K, -76% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $59K, +51% on a year earlier; public on 16 May 2023
Quarter ended 30 Jun 2023: $3K, -97% on a year earlier; public on 14 Oct 2023
Quarter ended 30 Sep 2023: $8K, -81% on a year earlier; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $5K, -88% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $45K, -25% on a year earlier; public on 16 May 2024
Quarter ended 30 Sep 2024: $47K, +464% on a year earlier; public on 15 Nov 2024
Quarter ended 30 Jun 2025: $10K; public on 30 Sep 2025
Quarter ended 30 Sep 2025: $84K, +80% on a year earlier; public on 15 Nov 2025
Quarter ended 30 Jun 2026: $1, -100% on a year earlier; public on 29 Sep 2026
Institutional holders (13F filers)
31 Dec 2021 report: 25; public on 14 Feb 2022
31 Mar 2022 report: 23; public on 16 May 2022
30 Jun 2022 report: 22; public on 15 Aug 2022
30 Sep 2022 report: 27; public on 14 Nov 2022
31 Dec 2022 report: 27; public on 14 Feb 2023
31 Mar 2023 report: 28; public on 15 May 2023
30 Jun 2023 report: 23; public on 14 Aug 2023
30 Sep 2023 report: 27; public on 14 Nov 2023
31 Dec 2023 report: 28; public on 14 Feb 2024
31 Mar 2024 report: 27; public on 15 May 2024
30 Jun 2024 report: 33; public on 14 Aug 2024
30 Sep 2024 report: 31; public on 14 Nov 2024
31 Dec 2024 report: 34; public on 14 Feb 2025
31 Mar 2025 report: 38; public on 15 May 2025
30 Jun 2025 report: 31; public on 14 Aug 2025
30 Sep 2025 report: 33; public on 14 Nov 2025
31 Dec 2025 report: 43; public on 17 Feb 2026
31 Mar 2026 report: 47; public on 15 May 2026
30 Jun 2026 report: 49; public on 14 Aug 2026
30 Sep 2026 report: 50; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is research and development expense, quarter at $4.7M (30 Sep 2026), 3.8× its normal quarter; higher than 100% of its own history.
  • Short interest spike: had 1.7M shares sold short in the 29 May 2026 report, 12× the same report last year Public on 10 Jun 2026.
  • Revenue per quarter: Revenue $0 in the latest quarter.
  • Capital spending per quarter: Capital spending $1 in the latest quarter, -100% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

50 institutions reported shares at the end of Q3 2026, 9% of the shares outstanding; 10 opened a position, 8 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Vanguard Capital Management LLC919K3.60%$1.2MNo change
Geode Capital Management, LLC229K0.90%$298K+13K+6.2%
BlackRock, Inc.159K0.62%$206KNo change
Miller Financial Services LLC134K0.52%$174K+22K+20%
Vanguard Fiduciary Trust Co132K0.52%$172KNo change
Susquehanna International Group, LLP126K0.49%$164K+66K+108%
Renaissance Technologies LLC98K0.38%$128K-30K-24%
Creative Planning87K0.34%$113KNo change
UBS Group AG70K0.28%$92K-29K-29%
Northern Trust Corp64K0.25%$83K+13K+25%

Company events

All 54 company events

In 12 months: 3 major agreements, 1 private placement, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
29 Sep 2026Director or officer change8-K
30 Jul 2026Signed a major agreement8-K
17 Jul 2026Signed a major agreement8-K
20 May 2026Signed a major agreement8-K
24 Feb 2026Private placement of securities (Form D)$6.0M sold of $6.0M offeredD
14 Nov 2025Signed a major agreementSame filing: sold shares privately8-K
1 Oct 2025Director or officer change8-K
9 Aug 2024Director or officer change8-K

The 5 newest of 44 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 29 Sep 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 29 Sep 2026Filings record

    Director or officer change

  3. 10 Jun 2026Short interest and volume change

    had 1.7M shares sold short in the 29 May 2026 report, 12× the same report last year.

    Same report last year: 135K; its normal report is 237K.

    See the evidence
    This period
    1.7M (the 29 May 2026 report)
    Normal report (median of 24 earlier)
    237K
    Typical spread (median absolute deviation)
    192K
    How far from its usual level
    +5.0
    Same report last year
    135K
    History used
    3,073 days
    2025-05-30: 135K2025-06-13: 88K2025-06-30: 242K2025-07-15: 106K2025-07-31: 85K2025-08-15: 42K2025-08-29: 204K2025-09-15: 232K2025-09-30: 59K2025-10-15: 46K2025-10-31: 117K2025-11-14: 228K2025-11-28: 177K2025-12-15: 430K2025-12-31: 458K2026-01-15: 658K2026-01-30: 790K2026-02-13: 844K2026-02-27: 963K2026-03-13: 805K2026-03-31: 756K2026-04-15: 732K2026-04-30: 714K2026-05-15: 702K2026-05-29: 1.7M
    the 29 May 2026 report24 earlier reportsnormal: 237K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 25 Mar 2026Short interest and volume change

    had 805K shares sold short in the 13 Mar 2026 report, 4.2× the same report last year.

    Same report last year: 194K; its normal report is 185K.

    See the evidence
    This period
    805K (the 13 Mar 2026 report)
    Normal report (median of 24 earlier)
    185K
    Typical spread (median absolute deviation)
    99K
    How far from its usual level
    +4.2
    Same report last year
    194K
    History used
    2,996 days
    2025-03-14: 194K2025-03-31: 145K2025-04-15: 331K2025-04-30: 130K2025-05-15: 70K2025-05-30: 135K2025-06-13: 88K2025-06-30: 242K2025-07-15: 106K2025-07-31: 85K2025-08-15: 42K2025-08-29: 204K2025-09-15: 232K2025-09-30: 59K2025-10-15: 46K2025-10-31: 117K2025-11-14: 228K2025-11-28: 177K2025-12-15: 430K2025-12-31: 458K2026-01-15: 658K2026-01-30: 790K2026-02-13: 844K2026-02-27: 963K2026-03-13: 805K
    the 13 Mar 2026 report24 earlier reportsnormal: 185K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 11 Mar 2026Short interest and volume change

    had 963K shares sold short in the 27 Feb 2026 report, 6.8× the same report last year.

    Same report last year: 141K; its normal report is 161K.

    See the evidence
    This period
    963K (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    161K
    Typical spread (median absolute deviation)
    75K
    How far from its usual level
    +7.2
    Same report last year
    141K
    History used
    2,982 days
    2025-02-28: 141K2025-03-14: 194K2025-03-31: 145K2025-04-15: 331K2025-04-30: 130K2025-05-15: 70K2025-05-30: 135K2025-06-13: 88K2025-06-30: 242K2025-07-15: 106K2025-07-31: 85K2025-08-15: 42K2025-08-29: 204K2025-09-15: 232K2025-09-30: 59K2025-10-15: 46K2025-10-31: 117K2025-11-14: 228K2025-11-28: 177K2025-12-15: 430K2025-12-31: 458K2026-01-15: 658K2026-01-30: 790K2026-02-13: 844K2026-02-27: 963K
    the 27 Feb 2026 report24 earlier reportsnormal: 161K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 26 Feb 2026Short interest and volume change

    had 844K shares sold short in the 13 Feb 2026 report, 6.0× the same report last year.

    Same report last year: 141K; its normal report is 143K.

    See the evidence
    This period
    844K (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    143K
    Typical spread (median absolute deviation)
    67K
    How far from its usual level
    +7.1
    Same report last year
    141K
    History used
    2,968 days
    2025-02-14: 141K2025-02-28: 141K2025-03-14: 194K2025-03-31: 145K2025-04-15: 331K2025-04-30: 130K2025-05-15: 70K2025-05-30: 135K2025-06-13: 88K2025-06-30: 242K2025-07-15: 106K2025-07-31: 85K2025-08-15: 42K2025-08-29: 204K2025-09-15: 232K2025-09-30: 59K2025-10-15: 46K2025-10-31: 117K2025-11-14: 228K2025-11-28: 177K2025-12-15: 430K2025-12-31: 458K2026-01-15: 658K2026-01-30: 790K2026-02-13: 844K
    the 13 Feb 2026 report24 earlier reportsnormal: 143K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 25 Feb 2026Filings record

    Private placement of securities (Form D) (dated 24 Feb 2026)

  8. 11 Feb 2026Short interest and volume change

    had 790K shares sold short in the 30 Jan 2026 report, 3.8× the same report last year.

    Same report last year: 210K; its normal report is 143K.

    See the evidence
    This period
    790K (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    143K
    Typical spread (median absolute deviation)
    64K
    How far from its usual level
    +6.8
    Same report last year
    210K
    History used
    2,954 days
    2025-01-31: 210K2025-02-14: 141K2025-02-28: 141K2025-03-14: 194K2025-03-31: 145K2025-04-15: 331K2025-04-30: 130K2025-05-15: 70K2025-05-30: 135K2025-06-13: 88K2025-06-30: 242K2025-07-15: 106K2025-07-31: 85K2025-08-15: 42K2025-08-29: 204K2025-09-15: 232K2025-09-30: 59K2025-10-15: 46K2025-10-31: 117K2025-11-14: 228K2025-11-28: 177K2025-12-15: 430K2025-12-31: 458K2026-01-15: 658K2026-01-30: 790K
    the 30 Jan 2026 report24 earlier reportsnormal: 143K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 28 Jan 2026Short interest and volume change

    had 658K shares sold short in the 15 Jan 2026 report, 3.6× the same report last year.

    Same report last year: 184K; its normal report is 143K.

    See the evidence
    This period
    658K (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    143K
    Typical spread (median absolute deviation)
    60K
    How far from its usual level
    +5.8
    Same report last year
    184K
    History used
    2,939 days
    2025-01-15: 184K2025-01-31: 210K2025-02-14: 141K2025-02-28: 141K2025-03-14: 194K2025-03-31: 145K2025-04-15: 331K2025-04-30: 130K2025-05-15: 70K2025-05-30: 135K2025-06-13: 88K2025-06-30: 242K2025-07-15: 106K2025-07-31: 85K2025-08-15: 42K2025-08-29: 204K2025-09-15: 232K2025-09-30: 59K2025-10-15: 46K2025-10-31: 117K2025-11-14: 228K2025-11-28: 177K2025-12-15: 430K2025-12-31: 458K2026-01-15: 658K
    the 15 Jan 2026 report24 earlier reportsnormal: 143K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 1 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  11. 1 Oct 2025Filings record

    Director or officer change

  12. 9 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 9 Aug 2024Filings record

    Director or officer change

  14. 28 Sep 2023Filings record

    Report will be filed late

  15. 26 Jul 2023Short interest and volume change

    had 626K shares sold short in the 14 Jul 2023 report, 3.3× the same report last year.

    Same report last year: 191K; its normal report is 171K.

    See the evidence
    This period
    626K (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    171K
    Typical spread (median absolute deviation)
    66K
    How far from its usual level
    +4.6
    Same report last year
    191K
    History used
    2,023 days
    2022-07-15: 191K2022-07-29: 171K2022-08-15: 245K2022-08-31: 191K2022-09-15: 161K2022-09-30: 158K2022-10-14: 159K2022-10-31: 171K2022-11-15: 153K2022-11-30: 126K2022-12-15: 113K2022-12-30: 112K2023-01-13: 93K2023-01-31: 93K2023-02-15: 93K2023-02-28: 90K2023-03-15: 184K2023-03-31: 247K2023-04-14: 352K2023-04-28: 410K2023-05-15: 324K2023-05-31: 390K2023-06-15: 422K2023-06-30: 433K2023-07-14: 626K
    the 14 Jul 2023 report24 earlier reportsnormal: 171K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 11 Oct 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 11 Oct 2022Filings record

    Director or officer change

  18. 29 Sep 2022Filings record

    Report will be filed late

  19. 28 Sep 2021Filings record

    Report will be filed late

  20. 15 Sep 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  21. 15 Sep 2021Filings record

    Director or officer change

  22. 19 Nov 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 19 Nov 2020Filings record

    Director or officer change

  24. 28 Sep 2020Filings record

    Report will be filed late

  25. 4 Jun 2020Filings record

    Director or officer change

  26. 19 May 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 19 May 2020Filings record

    Director or officer change

  28. 11 Mar 2020Short interest and volume change

    had 737K shares sold short in the 28 Feb 2020 report, 4.2× the same report last year.

    Same report last year: 174K; its normal report is 235K.

    See the evidence
    This period
    737K (the 28 Feb 2020 report)
    Normal report (median of 24 earlier)
    235K
    Typical spread (median absolute deviation)
    90K
    How far from its usual level
    +3.8
    Same report last year
    174K
    History used
    791 days
    2019-02-28: 174K2019-03-15: 78K2019-03-29: 184K2019-04-15: 311K2019-04-30: 224K2019-05-15: 307K2019-05-31: 289K2019-06-14: 413K2019-06-28: 344K2019-07-15: 416K2019-07-31: 373K2019-08-15: 355K2019-08-30: 246K2019-09-13: 147K2019-09-30: 11K2019-10-15: 147K2019-10-31: 137K2019-11-15: 144K2019-11-29: 132K2019-12-13: 150K2019-12-31: 192K2020-01-15: 253K2020-01-31: 923K2020-02-14: 328K2020-02-28: 737K
    the 28 Feb 2020 report24 earlier reportsnormal: 235K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 12 Feb 2020Short interest and volume change

    had 923K shares sold short in the 31 Jan 2020 report, 29× the same report last year.

    Same report last year: 32K; its normal report is 188K.

    See the evidence
    This period
    923K (the 31 Jan 2020 report)
    Normal report (median of 24 earlier)
    188K
    Typical spread (median absolute deviation)
    83K
    How far from its usual level
    +6.0
    Same report last year
    32K
    History used
    763 days
    2019-01-31: 32K2019-02-15: 60K2019-02-28: 174K2019-03-15: 78K2019-03-29: 184K2019-04-15: 311K2019-04-30: 224K2019-05-15: 307K2019-05-31: 289K2019-06-14: 413K2019-06-28: 344K2019-07-15: 416K2019-07-31: 373K2019-08-15: 355K2019-08-30: 246K2019-09-13: 147K2019-09-30: 11K2019-10-15: 147K2019-10-31: 137K2019-11-15: 144K2019-11-29: 132K2019-12-13: 150K2019-12-31: 192K2020-01-15: 253K2020-01-31: 923K
    the 31 Jan 2020 report24 earlier reportsnormal: 188K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 11 Feb 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  31. 11 Feb 2020Filings record

    Director or officer change

  32. 8 Jan 2020Filings record

    Registered new securities for sale (S-1)

  33. 7 Jan 2020Filings record

    Registered new securities for sale (S-1) (dated 6 Jan 2020)

  34. 23 Dec 2019Filings record

    Registered new securities for sale (S-1)

  35. 17 Dec 2019Filings record

    Registered new securities for sale (S-1) (dated 16 Dec 2019)

  36. 27 Nov 2019Filings record

    Registered new securities for sale (S-1)

  37. 14 Nov 2019Filings record

    Report will be filed late

  38. 28 Sep 2019Filings record

    Registered new securities for sale (S-1)

  39. 1 Aug 2019Filings record

    Director or officer change

  40. 10 Jun 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 52 entries; narrow the window or the kind of data to see older ones.

Not listed: 77 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001379006
Ticker
NNVC
Domain
nanoviricides.com
Hq location
CT|SHELTON|06484 (1 unverified)
Name
NanoViricides Inc.
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)110 records9 Feb 2016 to 16 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)840 data points30 Apr 2005 to 14 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4174 data points1 Aug 2018 to 20 Nov 2026